Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 87 of the 94 references it cites were found in a registry or an index; 33 of the 48 sources its claims cite were checked for support.

Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation

Open access

Abstract

There is currently no medical therapy to prevent calcific aortic valve stenosis (CAVS). Multi-omics approaches could lead to the identification of novel molecular targets. Here, we perform a genome-wide association study (GWAS) meta-analysis including 14,819 cases among 941,863 participants of European ancestry. We report 32 genomic loci, among which 20 are novel. RNA sequencing of 500 human aortic valves highlights an enrichment in expression regulation at these loci and prioritizes candidate causal genes. Homozygous genotype for a risk variant near TWIST1, a gene involved in endothelial-mesenchymal transition, has a profound impact on aortic valve transcriptomics. We identify five genes outside of GWAS loci by combining a transcriptome-wide association study, colocalization, and Mendelian randomization analyses. Using cross-phenotype and phenome-wide approaches, we highlight the role of circulating lipoproteins, blood pressure and inflammation in the disease process. Our findings pave the way for the development of novel therapies for CAVS.

Overview

CoChat Summary

TL;DR

This study integrates a large CAVS GWAS meta-analysis with RNA sequencing of human aortic valves to identify novel risk loci and candidate causal genes. It prioritizes tissue-specific regulatory mechanisms, including TWIST1, PRRX1, and ATP13A3, and links CAVS genetically to lipids, blood pressure, and inflammation.

Key findings

  • The GWAS meta-analysis included 14,819 CAVS cases and 927,044 controls of European ancestry and identified 32 genome-wide significant loci, 20 of which were novel; novel loci included LPL and LDLR.
  • RNA sequencing of 500 human aortic valves showed enrichment of eQTLs at CAVS loci: among 32 lead SNPs, 48 significant SNP-gene pairs were found in 20 loci, and the most significant eQTL was in aortic valve for 12 loci, including valve-specific signals for PALMD, TWIST1, NKX2-5, and TEX41.
  • Homozygous rs7804522-C near TWIST1 (66 individuals) versus homozygous rs7804522-G (138 individuals) in severe CAVS was associated with 509 differentially expressed genes at FDR <5% (148 up-regulated, 361 down-regulated), whereas other loci showed five or fewer differentially expressed genes.
  • TWAS, colocalization, and Mendelian randomization prioritized 10 genes; three were at genome-wide significant loci (PRRX1, ATP13A3, TWIST1), and five were outside GWAS loci (BCL10, RAD9A, NRBP1, FES, AFAP1). Cross-phenotype analyses identified 35 significantly associated phenotypes after Bonferroni correction, including plasma lipids, blood pressure traits, coronary artery disease, and leukocyte count.

Methods

  • GWAS meta-analysis across six cohorts of European ancestry used logistic regression per cohort and inverse-variance weighted fixed-effect meta-analysis in METAL; genome-wide significance was P < 5 × 10−8.
  • Aortic valve transcriptomics used bulk RNA sequencing of 500 human aortic valve samples from the QUEBEC-CAVS-RNA dataset; cis-eQTL analyses were performed in 484 samples with QTLtools, with comparisons to 43 GTEx tissues.
  • Downstream analyses included MAGMA gene-based analysis, TWAS with MetaXcan/S-PrediXcan, Bayesian colocalization with COLOC, Mendelian randomization, differential expression with edgeR, pathway enrichment, phenome-wide association, and LD-score regression genetic correlation.

Limitations

  • The paper states that cohorts included only individuals of European ancestry, so generalizability to other ancestries is unknown.
  • The paper states that complementary evidence is needed to understand the biological mechanisms by which identified genes impact CAVS risk.
  • The paper states that, except for QUEBEC-CAVS-1, cohorts included CAVS patients with bicuspid aortic valves, which could partly mediate risk for some loci, and that directionality and causal nature of cross-phenotype relationships remain to be determined. Evident from the text: candidate genes are prioritized through statistical integration, with no direct experimental functional validation reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-024-46639-4

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Manhattan plot of the genome-wide association studies meta-analysis for CAVS. The nearest gene at each genome-wide significant locus is indicated, in black for known loci and in red for novel loci. The association of each variant with calcific aortic valve stenosis was obtained from an inverse-variance weighted fixed-effect meta-analysis combining the effect per allele in the cohorts with available data. A p-value below 5 × 10−8 was considered significant (genome-wide threshold). The genomic inflation factor was 1.099 and the LD score regression intercept was 1.020. The quantile-quantile plot (inset) illustrates the distribution of p-values for each variant tested.
Fig. 1 Manhattan plot of the genome-wide association studies meta-analysis for CAVS. The nearest gene at each genome-wide significant locus is indicated, in black for known loci and in red for novel loci. The association of each variant with calcific aortic valve stenosis was obtained from an inverse-variance weighted fixed-effect meta-analysis combining the effect per allele in the cohorts with available data. A p-value below 5 × 10−8 was considered significant (genome-wide threshold). The genomic inflation factor was 1.099 and the LD score regression intercept was 1.020. The quantile-quantile plot (inset) illustrates the distribution of p-values for each variant tested.CC BY · PubMed Central
Fig. 2 Transcriptome-wide association study in human aortic valve and Mendelian randomization identify novel candidate causal genes at genome-wide significant loci. a, d, g LocusCompare plots at the PRRX1, ATP13A3, and TWIST1 loci. P for calcific aortic valve stenosis was obtained from the inverse-variance weighted fixed-effect GWAS meta-analysis. P for valve eQTL was obtained from the nominal association between genotype and normalized gene expression. b, e, h Boxplots showing normalized gene expression in human aortic valves according to the genotype at the lead SNP at the PRRX1, ATP13A3, and TWIST1 loci. The center mark in the box represents the median, the bounds of the box represent the 25th and 75th percentiles and the whiskers are the most extreme data point, which is no more than 1.5 times the interquartile range. P GWAS was obtained from the inverse-variance weighted fixed-effect GWAS meta-analysis. P eQTL was obtained from the nominal association between genotype and normalized gene expression. The allele in red is the risk allele. c, f, i Scatterplot representing the effect of each SNP selected in the instrument for the Mendelian randomization (MR) analysis on gene expression in human aortic valves (n = 484) and risk of calcific aortic valve stenosis (n = 14,819 cases and 927,044 controls) at the PRRX1, ATP13A3, and TWIST1 loci. Data are presented as the effect and 95% confidence interval (+/−1.96*standard error). Red line: inverse-variant weighted (IVW) MR; Dotted red lines: 95% confidence interval for IVW MR; Green line: Weighted median MR; Pink line: Egger MR.
Fig. 2 Transcriptome-wide association study in human aortic valve and Mendelian randomization identify novel candidate causal genes at genome-wide significant loci. a, d, g LocusCompare plots at the PRRX1, ATP13A3, and TWIST1 loci. P for calcific aortic valve stenosis was obtained from the inverse-variance weighted fixed-effect GWAS meta-analysis. P for valve eQTL was obtained from the nominal association between genotype and normalized gene expression. b, e, h Boxplots showing normalized gene expression in human aortic valves according to the genotype at the lead SNP at the PRRX1, ATP13A3, and TWIST1 loci. The center mark in the box represents the median, the bounds of the box represent the 25th and 75th percentiles and the whiskers are the most extreme data point, which is no more than 1.5 times the interquartile range. P GWAS was obtained from the inverse-variance weighted fixed-effect GWAS meta-analysis. P eQTL was obtained from the nominal association between genotype and normalized gene expression. The allele in red is the risk allele. c, f, i Scatterplot representing the effect of each SNP selected in the instrument for the Mendelian randomization (MR) analysis on gene expression in human aortic valves (n = 484) and risk of calcific aortic valve stenosis (n = 14,819 cases and 927,044 controls) at the PRRX1, ATP13A3, and TWIST1 loci. Data are presented as the effect and 95% confidence interval (+/−1.96*standard error). Red line: inverse-variant weighted (IVW) MR; Dotted red lines: 95% confidence interval for IVW MR; Green line: Weighted median MR; Pink line: Egger MR.CC BY · PubMed Central
Fig. 3 Impact of homozygous risk genotype near TWIST1 on aortic valve gene expression. a Volcano plot representing the differentially expressed genes between individuals homozygous for rs7804522-C and individuals homozygous for rs7804522-G. Red points represent up-regulated genes (n = 148). Blue points represent down-regulated genes (n = 361). Statistical significance was set at P ≤ 0.001 corresponding to false-discovery rate <5% in the differential expression analysis. The top 10 up and down-regulated genes are labeled. b Lead independent enriched terms for the dysregulated genes. The statistical significance of the association for each term was obtained from a hypergeometric test and is illustrated by the color (p-value). The number of overlapping genes is illustrated by the size of the bubble.
Fig. 3 Impact of homozygous risk genotype near TWIST1 on aortic valve gene expression. a Volcano plot representing the differentially expressed genes between individuals homozygous for rs7804522-C and individuals homozygous for rs7804522-G. Red points represent up-regulated genes (n = 148). Blue points represent down-regulated genes (n = 361). Statistical significance was set at P ≤ 0.001 corresponding to false-discovery rate <5% in the differential expression analysis. The top 10 up and down-regulated genes are labeled. b Lead independent enriched terms for the dysregulated genes. The statistical significance of the association for each term was obtained from a hypergeometric test and is illustrated by the color (p-value). The number of overlapping genes is illustrated by the size of the bubble.CC BY · PubMed Central
Fig. 4 Genes with multiple features suggesting their implication in CAVS. Nearest gene: gene closest to a lead SNP in the GWAS meta-analysis; Intronic: annotation of the lead SNP in the meta-analysis; Missense or nonsense: lead GWAS SNP is in linkage disequilibrium (r2 ≥ 0.8) with a missense or nonsense variant for the gene; MAGMA: significant in MAGMA analysis at P < 0.00039 corresponding to false discovery rate <5%; High expression in valve: above the 90th percentile of all protein-coding genes; Valve-specific expression: expression specificity score >0.1; COLOC: colocalization PP4 > 0.75; Valve eQTL: significant eQTL; TWAS: significant in transcriptome-wide association study at P < 0.00017 corresponding to false discovery rate <5%; MR: significant in Mendelian randomization analyses (P < 0.05). Gold squares indicate a significant positive association; Blue squares indicate a significant negative association.
Fig. 4 Genes with multiple features suggesting their implication in CAVS. Nearest gene: gene closest to a lead SNP in the GWAS meta-analysis; Intronic: annotation of the lead SNP in the meta-analysis; Missense or nonsense: lead GWAS SNP is in linkage disequilibrium (r2 ≥ 0.8) with a missense or nonsense variant for the gene; MAGMA: significant in MAGMA analysis at P < 0.00039 corresponding to false discovery rate <5%; High expression in valve: above the 90th percentile of all protein-coding genes; Valve-specific expression: expression specificity score >0.1; COLOC: colocalization PP4 > 0.75; Valve eQTL: significant eQTL; TWAS: significant in transcriptome-wide association study at P < 0.00017 corresponding to false discovery rate <5%; MR: significant in Mendelian randomization analyses (P < 0.05). Gold squares indicate a significant positive association; Blue squares indicate a significant negative association.CC BY · PubMed Central
Fig. 5 Lead SNPs at GWAS and TWAS loci are associated with cardiovascular traits in UK Biobank. The nearest gene is indicated on the x-axis; * denotes TWAS loci. The traits are from the following categories: blood lipids (orange), blood pressure (brown), anthropometric traits (gray), cardiovascular diseases (red), diabetes (blue) and others (green). The effect size and statistical significance of the genetic association with the phenotype in UK Biobank are illustrated by the color (Z-score) and the size of the bubble (p-value).
Fig. 5 Lead SNPs at GWAS and TWAS loci are associated with cardiovascular traits in UK Biobank. The nearest gene is indicated on the x-axis; * denotes TWAS loci. The traits are from the following categories: blood lipids (orange), blood pressure (brown), anthropometric traits (gray), cardiovascular diseases (red), diabetes (blue) and others (green). The effect size and statistical significance of the genetic association with the phenotype in UK Biobank are illustrated by the color (Z-score) and the size of the bubble (p-value).CC BY · PubMed Central
Fig. 6 Genetic correlation between CAVS and cardiovascular traits. Data are presented as genetic correlation (rg) and 95% confidence interval (+/−1.96*standard error). The traits are from the following categories: blood lipids (orange), blood pressure (brown), anthropometric traits (gray), cardiovascular diseases (red), diabetes (blue) and others (green). LDL low-density lipoprotein, HDL high-density lipoprotein, BMI body mass index, WHR waist-to-hip ratio, WHRadjBMI waist-to-hip ratio adjusted for body mass index.
Fig. 6 Genetic correlation between CAVS and cardiovascular traits. Data are presented as genetic correlation (rg) and 95% confidence interval (+/−1.96*standard error). The traits are from the following categories: blood lipids (orange), blood pressure (brown), anthropometric traits (gray), cardiovascular diseases (red), diabetes (blue) and others (green). LDL low-density lipoprotein, HDL high-density lipoprotein, BMI body mass index, WHR waist-to-hip ratio, WHRadjBMI waist-to-hip ratio adjusted for body mass index.CC BY · PubMed Central

Verification

Claims the paper makes

25 Valid · 3 Not valid · 15 Not checked · 107 Own results and interpretations

59 more claims

Create a free account to see all 150 claims and to verify the 4 references still open.

See all claims — free account
  • Probably not a substantial claim. 52
  • It may state two separate claims as one. 51

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 94 references

Cited by

See all 49

Metadata

Authors
Thériault, S., Li, Z., Abner, E., Luan, J., Manikpurage, H. D., Houessou, U., Zamani, P., Briend, M., Estonian Biobank Research Team, Boudreau, D. K., Gaudreault, N., Frenette, L., Argaud, D., Dahmene, M., Dagenais, F., Clavel, M.-A., Pibarot, P., Arsenault, B. J., Boekholdt, S. M., Wareham, N. J., Esko, T., Mathieu, P., & Bossé, Y.
Affiliations
  • Institut universitaire de cardiologie et de pneumologie de Québec (CA)
  • University of Tartu (EE)
  • University of Cambridge (GB)
  • Amsterdam University Medical Centers (NL)
Corresponding author
Thériault, Sébastien
Venue
Nature Communications
Published
2024-03-18
Volume
15
Issue
1
Pages
2407-2407
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4392923711
Cited by
49
References
94
Citations by year
2026: 17 · 2025: 24 · 2024: 7
FWCI
3.80
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (acceptedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Corpus Université Laval (Université Laval) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Gouvernement du Canada | Canadian Institutes of Health Research (PJT-162344)
  • Heart and Stroke Foundation of Canada (G-19-0026386)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
Keywords
calcific aortic stenosis, tissue-specific gene regulation, TWIST1, endothelial-to-mesenchymal transition, transcriptome-wide association study, colocalization, Mendelian randomization, lipoproteins, blood pressure, inflammation, genetic susceptibility loci, multi-omics
MeSH terms
Aortic Valve, Aortic Valve Stenosis, Calcinosis, Humans, Genomics, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation. https://app.cochat.ai/papers/10.1038/s41467-024-46639-4
The paper
Thériault, S., Li, Z., Abner, E., Luan, J., Manikpurage, H. D., Houessou, U., Zamani, P., Briend, M., Estonian Biobank Research Team, Boudreau, D. K., Gaudreault, N., Frenette, L., Argaud, D., Dahmene, M., Dagenais, F., Clavel, M.-A., Pibarot, P., Arsenault, B. J., Boekholdt, S. M., . . . Bossé, Y. (2024). Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation. Nature Communications. https://doi.org/10.1038/s41467-024-46639-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.